WHO Grade 4 Glioma Clinical Trials

6 clinical trials for WHO Grade 4 Glioma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma — RECRUITING · NA
• An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma — RECRUITING · PHASE2
• Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas — RECRUITING · PHASE1
• Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) — NOT_YET_RECRUITING · PHASE2
• Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG — NOT_YET_RECRUITING · PHASE2

Refine this search